<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="33">
  <stage>Registered</stage>
  <submitdate>18/07/2005</submitdate>
  <approvaldate>19/07/2005</approvaldate>
  <actrnumber>ACTRN12605000023651</actrnumber>
  <trial_identification>
    <studytitle>The Treatment of Non-synostotic Plagiocephaly and Brachycephaly in Infants</studytitle>
    <scientifictitle>A randomised, controlled trial to assess the effectiveness of positioning treatment to improve head shape measurements in infants with non-synostotic plagiocephaly and brachycephaly, using (1) in severe cases, either a sleep positioning wrap or a head positioning helmet, and (2) in mild to moderate cases, either education alone or education plus a sleep positioning wrap.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Non-synostotic plagiocephaly</healthcondition>
    <healthcondition>Non-synostotic brachycephaly</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Infants under the age of 12 months and diagnosed with non-synostotic plagiocephaly or brachycephaly are categorised as (1) severe or (2) mild-moderate, according to objective head shape measurements of cephalic index or oblique cranial length ratio.  Group (1) is randomised to either a sleep positioning wrap or a head positioning helmet; Group (2) is randomised to education alone or education plus a sleep positioning wrap.   Infants are followed up 3, 6, and 12 months after initiation of treatment to assess the effectiveness of treatment.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Head shape, specifically the change in cephalic index and oblique cranial length ratio.</outcome>
      <timepoint>Measured 3, 6 and 12 months after initiation of treatment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>For Group (2), a change in developmental score</outcome>
      <timepoint>Between baseline and 12 months, using the Bayley Scales of Infant Development, 2nd Edition.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Any child under 12 months of age, and diagnosed with non-synostotic plagiocephaly or brachycephaly</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>12</inclusivemaxage>
    <inclusivemaxagetype>Months</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Craniosynostosis, congenital abnomalities, older than 12 months, residing (or planning to move) outside Auckland, Counties Manukau, or Waitemata District Health Board areas, currently using a Safe T Sleep sleep positioning device.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed letter with ID on outside, prepared by person other than researcher, opened at the moment of assignment.</concealment>
    <sequence>Computer-generated random allocation of treatment to ID number.  Each successive infant enrolled receives the next consecutive ID number.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/05/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>308</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Ed Mitchell, University of Auckland.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Child Health Research Foundation</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname> Auckland Medical Research Foundation</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Lynne Hutchison</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Tristan de Chalain</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Mr Alistair Stewart</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Auckland Regional Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Auckland District Health Board</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Counties Manukau District Health Board</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Ed Mitchell</name>
      <address>Department of Paediatrics
University of Auckland
Private Bag 92019
Auckland 1</address>
      <phone>+64 9 3737599 (Ext. 86431)</phone>
      <fax>+64 9 3737486</fax>
      <email>e.mitchell@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Lynne Hutchison</name>
      <address>Department of Paediatrics
University of Auckland
Private Bag 92019
Auckland 1</address>
      <phone>+64 9 3737599 (Ext. 83979)</phone>
      <fax>+64 9 3737486</fax>
      <email>bl.hutchison@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>